Pivotal role of antibody and subsidiary contribution of cd8 + T cells to recovery from infection in a murine model of Japanese encephalitis

Journal of Virology

Volumn 85, Issue 11, 2011, Pages 5446-5455

  Larena, Maximilian ^a   Regner, Matthias ^a   Lee, Eva ^a   Lobigs, Mario ^a  

^a Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; FAS ANTIGEN; GRANZYME; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; ANTIBODIES, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS, JAPANESE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RODENT DISEASES; SURVIVAL ANALYSIS;

ANIMALIA; JAPANESE ENCEPHALITIS VIRUS; MURINAE; MUS; WEST NILE VIRUS;

EID: 79956071567     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02611-10     Document Type: Article

References (49)

1. Adachi, M., et al. 1995. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11:294-300.
2. Arjona, A., et al. 2007. West Nile virus envelope protein inhibits dsRNAinduced innate immune responses. J. Immunol. 179:8403-8409.
3. Beasley, D. W., P. Lewthwaite, and T. Solomon. 2008. Current use and development of vaccines for Japanese encephalitis. Expert Opin. Biol. Ther. 8:95-106.
4. Biswas, S. M., V. M. Ayachit, G. N. Sapkal, S. A. Mahamuni, and M. M. Gore. 2009. Japanese encephalitis virus produces a CD4+ Th2 response and associated immunoprotection in an adoptive-transfer murine model. J. Gen. Virol. 90:818-826.
5. Brien, J. D., J. L. Uhrlaub, and J. Nikolich-Zugich. 2007. Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur. J. Immunol. 37:1855-1863.
6. Burke, D. S., et al. 1985. Fatal outcome in Japanese encephalitis. Am. J. Trop. Med. Hyg. 34:1203-1210.
7. Burrow, J. N., et al. 1998. Australian encephalitis in the Northern Territory: clinical and epidemiological features, 1987-1996. Aust. N.Z. J. Med. 28:590-596.
8. Chambers, T. J., et al. 2008. West Nile 25A virus infection of B-cell-deficient ((micro)MT) mice: characterization of neuroinvasiveness and pseudoreversion of the viral envelope protein. J. Gen. Virol. 89:627-635.
9. Clark, D. C., et al. 2007. In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein. J. Gen. Virol. 88:1175-1183.
10. Colombage, G., R. Hall, M. Pavy, and M. Lobigs. 1998. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology 250:151-163.
11. Daffis, S., M. A. Samuel, M. S. Suthar, M. Gale, Jr., and M. S. Diamond. 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 82:10349-10358.
12. Diamond, M. S., B. Shrestha, A. Marri, D. Mahan, and M. Engle. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77:2578-2586.
13. Goncalvez, A. P., et al. 2008. Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo. J. Virol. 82:7009-7021.
14. Gupta, A. K., V. J. Lad, and A. A. Koshy. 2003. Protection of mice against experimental Japanese encephalitis virus infections by neutralizing anti-glycoprotein E monoclonal antibodies. Acta Virol. 47:141-145.
15. Halstead, S. B., and J. Jacobson. 2003. Japanese encephalitis. Adv. Virus Res. 61:103-138.
16. Kägi, D., et al. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37.
17. Kesson, A. M., R. V. Blanden, and A. Müllbacher. 1987. The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile. J. Gen. Virol. 68(Pt. 7):2001-2006.
18. Kimura-Kuroda, J., and K. Yasui. 1988. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol. 141:3606-3610.
19. Kitamura, D., and K. Rajewsky. 1992. Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356:154-156.
20. Klein, R. S., and M. S. Diamond. 2008. Immunological headgear: antiviral immune responses protect against neuroinvasive West Nile virus. Trends Mol. Med. 14:286-294.
21. Lee, E., R. A. Hall, and M. Lobigs. 2004. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J. Virol. 78:8271-8280.
22. Lee, E., and M. Lobigs. 2002. Mechanism of virulence attenuation of GAGbinding variants of Japanese encephalitis and Murray Valley encephalitis viruses. J. Virol. 76:4901-4911.
23. Libraty, D. H., et al. 2002. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans. R. Soc. Trop. Med. Hyg. 96:173-178.
24. Licon Luna, R. M., et al. 2002. Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice. J. Virol. 76:3202-3211.
25. Lim, P. Y., K. L. Louie, L. M. Styer, P. Y. Shi, and K. A. Bernard. 2010. Viral pathogenesis in mice is similar for West Nile virus derived from mosquito and mammalian cells. Virology 400:93-103.
26. Lindsey, N. P., J. E. Staples, J. A. Lehman, and M. Fischer. 2010. Surveillance for human West Nile virus disease-United States, 1999-2008. MMWR Surveill. Summ. 59:1-17.
27. Lobigs, M., et al. 2010. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses. J. Gen. Virol. 91:1407-1417.
28. Mackenzie, J. S., D. J. Gubler, and L. R. Petersen. 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10:S98-S109.
29. Madsen, L., et al. 1999. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. U. S. A. 96:10338-10343.
30. Monath, T. P., et al. 2003. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J. Infect. Dis. 188: 1213-1230.
31. Müllbacher, A., M. Lobigs, and E. Lee. 2003. Immunobiology of mosquitoborne encephalitic flaviviruses. Adv. Virus Res. 60:87-120.
32. Müllbacher, A., et al. 2004. Can we really learn from model pathogens? Trends Immunol. 25:524-528.
33. Murali-Krishna, K., V. Ravi, and R. Manjunath. 1996. Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells. J. Gen. Virol. 77:705-714.
34. Pierson, T. C., D. H. Fremont, R. J. Kuhn, and M. S. Diamond. 2008. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4:229-238.
35. Purtha, W. E., et al. 2007. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur. J. Immunol. 37:1845-1854.
36. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219.
37. Shrestha, B., and M. S. Diamond. 2007. Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system. J. Virol. 81:11749-11757.
38. Shrestha, B., and M. S. Diamond. 2004. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78:8312-8321.
39. Shrestha, B., M. A. Samuel, and M. S. Diamond. 2006. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 80:119-129.
40. Silva, M. C., A. Guerrero-Plata, F. D. Gilfoy, R. P. Garofalo, and P. W. Mason. 2007. Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J. Virol. 81:13640-13648.
41. Simon, M. M., et al. 1997. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J. Exp. Med. 186:1781-1786.
42. Sitati, E. M., and M. S. Diamond. 2006. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 80:12060-12069.
43. Solomon, T. 2004. Flavivirus encephalitis. N. Engl. J. Med. 351:370-378.
44. Trobaugh, D. W., L. Yang, F. A. Ennis, and S. Green. 2010. Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses. Eur. J. Immunol. 40:1315-1327.
45. Tscharke, D. C., et al. 2005. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201:95-104.
46. Wang, Y., M. Lobigs, E. Lee, and A. Müllbacher. 2003. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 77:13323-13334.
47. Wang, Y., M. Lobigs, E. Lee, and A. Müllbacher. 2004. Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice. Immunol. Cell Biol. 82:170-173.
48. Zhang, M. J., M. J. Wang, S. Z. Jiang, and W. Y. Ma. 1989. Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies. J. Med. Virol. 29:133-138.
49. Zhu, J., H. Yamane, and W. E. Paul. 2010. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28:445-489.